No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Dexferrum is a hematological drug used to treat iron deficiency anemia. It is a form of iron sucrose, a complex of iron and sucrose molecules, which is administered intravenously. Dexferrum is used to replenish iron stores in patients with iron deficiency anemia, and is also used to treat anemia caused by chronic kidney disease. It is available in both single-dose and multi-dose vials, and is administered by a healthcare professional.
The Dexferrum market is composed of a variety of companies that produce and distribute the drug. These companies include major pharmaceutical companies such as Pfizer, Novartis, and Sanofi, as well as smaller companies such as Fresenius Kabi and Baxter International. These companies are responsible for the production, distribution, and marketing of Dexferrum, and are key players in the hematological drug market. Show Less Read more
